Table of Contents

company-logo

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.

Theralink Technologies Dividend Announcement

• Theralink Technologies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Theralink Technologies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Theralink Technologies Dividend History

Theralink Technologies Dividend Yield

Theralink Technologies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Theralink Technologies stock? Use our calculator to estimate your expected dividend yield:

Theralink Technologies Financial Ratios

P/E ratio0.04
PEG ratio-0.00
P/B ratio-0.02
ROE-32.97%
Payout ratio0.00%
Current ratio0.03
Quick ratio0.03
Cash Ratio0.03

Theralink Technologies Dividend FAQ

Does Theralink Technologies stock pay dividends?
Theralink Technologies does not currently pay dividends to its shareholders.
Has Theralink Technologies ever paid a dividend?
No, Theralink Technologies has no a history of paying dividends to its shareholders. Theralink Technologies is not known for its dividend payments.
Why doesn't Theralink Technologies pay dividends?
There are several potential reasons why Theralink Technologies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Theralink Technologies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Theralink Technologies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Theralink Technologies a dividend aristocrat?
Theralink Technologies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Theralink Technologies a dividend king?
Theralink Technologies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Theralink Technologies a dividend stock?
No, Theralink Technologies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Theralink Technologies stocks?
To buy Theralink Technologies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Theralink Technologies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.